Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients

By Hall K.S.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 235-244

Springer Publishing Company

Access to resources Recommend Favorite

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

By Buchholz Thomas  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 53-55

Informa Healthcare

Access to resources Recommend Favorite

A Phase I Toxicity and Feasibility Trial of Sequential Dose-Dense Induction Chemotherapy with Doxorubicin, Paclitaxel, and 5-Fluorouracil Followed by High Dose Consolidation for High-Risk Primary Breast Cancer

By Emens L.A.   Kennedy M.J.   Fetting J.H.   Davidson N.E.   Garrett E.   Armstrong D.K.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 145-156

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis Sustains Tumor Dormancy in Patients with Breast Cancer Treated with Adjuvant Chemotherapy

By Gasparini G.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 1, 2001-01 ,pp. : 71-75

Springer Publishing Company

Access to resources Recommend Favorite